Use Of Surrogate Endpoints In Oncology

Use of Surrogate Endpoints in Oncology

Lecture 2 - Surrogate Endpoints in Oncology - Reading and Interpreting Cancer Trials

Vinay Prasad MD MPH

Validating Surrogate Endpoints in Oncology

IDDI

Introduction to endpoints in oncology clinical trials

On Surrogate Endpoints in Oncology

Lecture Medical Oncology - Endpoints in clinical trials

European Association of Urology

Surrogate Endpoints in Oncology and their role in regulatory approval

Choosing cancer clinical trial endpoints

Surrogate endpoints | What do they mean?

HealthTree University Myeloma

The use of surrogate endpoints in CLL clinical trials

VJHemOnc – Video Journal of Hematology & HemOnc

Surrogate Endpoints in Solid and Liquid Tumors

Chadi Nabhan and Healthcare Unfiltered

Biomarkers and Surrogate Endpoints in Drug Development

Health Plan Take on the Cancer Drug Approval Process and Surrogate Endpoints

What are the surrogate endpoints in AML?

endpoints, clinical trial outcomes, & surrogate endpoints

How to Define & Measure Clinical Endpoints to Optimize Your Oncology Drug Dosing

Statistical Considerations on the Use of Surrogate Endpoints | Thomas Fleming

Arthritis Foundation

Assessing intermediate clinical endpoints as potential surrogates for OS in prostate cancer

Oncology Clinical Trials: Why We're Searching for Emerging Endpoints

ZS

Lecture 3 - FDA Drug Approval 101- Reading and Interpreting Cancer Trials Series

Vinay Prasad MD MPH